GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xylo Technologies Ltd (NAS:XYLO) » Definitions » PB Ratio

Xylo Technologies (Xylo Technologies) PB Ratio : 0.13 (As of Apr. 26, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Xylo Technologies PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-26), Xylo Technologies's share price is $1.64. Xylo Technologies's Book Value per Share for the quarter that ended in Dec. 2023 was $12.64. Hence, Xylo Technologies's PB Ratio of today is 0.13.

Good Sign:

Xylo Technologies Ltd stock PB Ratio (=0.13) is close to 10-year low of 0.12

The historical rank and industry rank for Xylo Technologies's PB Ratio or its related term are showing as below:

XYLO' s PB Ratio Range Over the Past 10 Years
Min: 0.12   Med: 0.84   Max: 2.44
Current: 0.13

During the past 12 years, Xylo Technologies's highest PB Ratio was 2.44. The lowest was 0.12. And the median was 0.84.

XYLO's PB Ratio is ranked better than
99.25% of 795 companies
in the Medical Devices & Instruments industry
Industry Median: 2.19 vs XYLO: 0.13

During the past 12 months, Xylo Technologies's average Book Value Per Share Growth Rate was -46.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -16.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -11.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -41.90% per year.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Xylo Technologies was -0.80% per year. The lowest was -67.80% per year. And the median was -43.55% per year.

Back to Basics: PB Ratio


Xylo Technologies PB Ratio Historical Data

The historical data trend for Xylo Technologies's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xylo Technologies PB Ratio Chart

Xylo Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.07 1.32 0.48 0.20 0.26

Xylo Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.35 0.20 0.26 0.26

Competitive Comparison of Xylo Technologies's PB Ratio

For the Medical Devices subindustry, Xylo Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xylo Technologies's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xylo Technologies's PB Ratio distribution charts can be found below:

* The bar in red indicates where Xylo Technologies's PB Ratio falls into.



Xylo Technologies PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Xylo Technologies's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=1.64/12.635
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Xylo Technologies  (NAS:XYLO) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Xylo Technologies PB Ratio Related Terms

Thank you for viewing the detailed overview of Xylo Technologies's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Xylo Technologies (Xylo Technologies) Business Description

Traded in Other Exchanges
Address
10 Hanechoshet Street, 4th Floor, Tel Aviv, ISR, 6971072
Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company also develops a range of micro video cameras under the micro ScoutCam portfolio of products. It operates in five segments: Medical, E-Commerce, Online, Electric Vehicles, and Corporate. The company's geographical segments include the United States, United Kingdom, Germany, Israel, China, and Others.